Executive Summary
A remarkable clustering of 41 8-K filings on January 28, 2026, all disclosing Item 5.02 board/officer changes (departures, appointments, elections, compensatory arrangements), spans diverse sectors including financials (e.g., US Bancorp, Valley National Bancorp, ~10 firms), industrials/transport (Schneider National, ArcBest, RPC Inc., ~7), healthcare/biotech (Pacira BioSciences, SenesTech, Sonoma Pharmaceuticals, ~6), consumer/retail (El Pollo Loco, Kohl's, VF Corp., ~5), and others like funds and tech. All filings exhibit neutral sentiment with average materiality of 4.4/10 and low-to-medium risk levels, but uniform lack of specifics on positions (e.g., no CEO/CFO mentions), reasons, or successors creates opacity risks across the board. No period-over-period financial trends, insider trading activity, capital allocation details, or forward-looking guidance are disclosed in summaries, though 12 filings include Item 7.01 (Reg FD) potentially tying leadership shifts to operational updates. 7 filings pair changes with Item 2.02 results or Item 5.07 shareholder votes, suggesting end-of-period governance refreshes possibly linked to 2025 performance. Portfolio implication: Broad board turnover wave may signal proactive succession planning or hidden instability; monitor follow-on filings for details amid neutral sentiment. Actionable now: Avoid new positions until clarity emerges, but overweight sectors with Item 7.01 for potential catalysts.
Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from January 26, 2026.
Investment Signals(12)
- RPC Inc↓(NEUTRAL TO BULLISH)▲
Officer change under Item 5.02 paired with Item 8.01 other events, neutral sentiment but low risk signals stable transition in energy services sector
- Progressive Corp/OH/↓(BULLISH)▲
Item 5.02 officer change with Item 2.02 results disclosure, filing size 624 KB indicates detailed exhibits potentially supporting strong Q4 insurance metrics
- Jabil Inc↓(BULLISH)▲
Electronics manufacturing leader discloses Item 5.02 change with exhibits, low risk amid supply chain resilience suggests continuity
- Workiva Inc↓(BULLISH)▲
Software firm Item 5.02 + Item 7.01 Reg FD, medium risk but higher 6/10 materiality flags potential positive guidance on leadership enhancement
- Accenture plc↓(BULLISH)▲
Consulting giant Item 5.02 with Item 5.07 votes, low risk points to approved board refresh strengthening global expertise
- US Bancorp↓(BULLISH)▲
Major bank Item 5.02 low materiality 3/10, stable financial sector transition without disclosed disruptions
- Schneider National↓(BULLISH)▲
Trucking Item 5.02 + Item 7.01, low risk amid logistics boom suggests operational continuity
- ARCBEST Corp↓(BULLISH)▲
Transport peer to Schneider with Item 5.02 + Item 7.01, medium risk but paired disclosures imply coordinated sector stability
- KB Home↓(BULLISH)▲
Homebuilder Item 5.02 low risk, potential alignment with housing recovery trends
- El Pollo Loco↓(NEUTRAL TO BULLISH)▲
Restaurant chain Item 5.02 + Item 7.01, medium risk 5/10 but Reg FD hints at consumer resilience
- Pacira BioSciences↓(BULLISH)▲
Biotech Item 5.02 + Item 7.01, medium risk flags potential pipeline acceleration via leadership
- Valley National Bancorp↓(BULLISH)▲
Regional bank Item 5.02 low materiality, sector pattern of routine changes supports stability
Risk Flags(10)
- Zeo ScientifiX, Inc./Officer Change↓[MEDIUM RISK]▼
Lack of details on position/reason may hide instability, materiality 4/10
- ▼
No officer name/title disclosed, potential instability signal, risk low but opaque
- Marine Products Corp/Disclosure Gap↓[MEDIUM RISK]▼
No quantitative impacts or reasons, could mask sudden departure issues
- Ultra Clean Holdings/Semicon Equip↓[MEDIUM RISK]▼
Undisclosed governance details amid chip cycle risks
- Pacira BioSciences/Biotech↓[HIGH RISK]▼
Medium risk on officer change opacity + Item 7.01, potential undisclosed uncertainty
- El Pollo Loco/Restaurant↓[HIGH RISK]▼
Medium risk 5/10, critical successor details missing post-weak consumer trends
- FIRST COMMONWEALTH FINANCIAL/Financial↓[MEDIUM RISK]▼
Item 5.02 + Item 2.02 but unknown change details signal instability
- ▼
Item 5.03 bylaws change + unknown officer details, medium risk
- Workiva Inc/Software↓[MEDIUM RISK]▼
Medium risk, higher 6/10 materiality with no position/reason disclosed
- SenesTech, Inc./Biotech↓[MEDIUM RISK]▼
Medium risk 5/10, no key position or reason in pest control niche
Opportunities(10)
- ◆
Potential improved governance/expertise from Item 5.02 appointments, monitor bylaws Item 5.03
- Ocean Power Technologies/Board Refresh↓(OPPORTUNITY)◆
Item 5.02 + Item 5.07 votes suggest strengthened expertise in renewables, potential turnaround
- Pasithea Therapeutics/Governance Shift↓(OPPORTUNITY)◆
Item 5.02/5.03/5.07 combo offers board refresh in biotech, alpha if positive votes
- Progressive Corp/Insurance Results↓(OPPORTUNITY)◆
Item 2.02 + 5.02 ties leadership to Q4 results, overweight if exhibits show premium growth
- Workiva Inc/Reg FD Catalyst↓(OPPORTUNITY)◆
Item 7.01 with officer change, higher materiality 6/10 for SaaS guidance upside
- Pacira BioSciences/Pipeline↓(OPPORTUNITY)◆
Item 7.01 + 5.02, medium risk but biotech leadership change could accelerate approvals
- ARCBEST Corp/Transport↓(OPPORTUNITY)◆
Item 7.01 disclosure with change, relative to Schneider for logistics volume outperformance
- TON Strategy Co/Strategic Shift↓(OPPORTUNITY)◆
Item 7.01 + 5.02, 6/10 materiality for potential turnaround via new leadership
- KB Home/Housing↓(OPPORTUNITY)◆
Routine Item 5.02 low risk amid rate cut expectations, undervalued homebuilder entry
- Accenture plc/Votes↓(OPPORTUNITY)◆
Item 5.07 approvals + 5.02, consulting demand supports board stability alpha
Sector Themes(6)
- Financials Board Wave (10/41 filings)◆
Banks like US Bancorp, Valley National, First Commonwealth, Burke & Herbert, Colony disclose Item 5.02 changes (avg materiality 4/10, low risk); pattern suggests routine Q4 refreshes, no disclosed instability but opacity warrants caution vs sector NIM trends
- Transport/Logistics Turnover (Schneider, ARCBEST, ~5 firms)◆
Item 5.02 + frequent Item 7.01 Reg FD (no metrics disclosed), neutral sentiment amid freight cycle; clustering may signal capacity optimization via leadership
- Biotech/Healthcare Opacity (~6 firms: Pacira, SenesTech, Sonoma, Pasithea)◆
Medium risk avg, lack of position/reason details + some Item 7.01; theme of undisclosed shifts post-clinical updates, watch for pipeline catalysts
- Funds/Governance Amendments (Highland Opportunities/Global, ~3)◆
Item 5.02/5.03 combos, medium risk; pattern of bylaws tweaks with changes implies structural resets for yield enhancement
- Retail/Consumer Resilience (El Pollo Loco, Kohl's, VF Corp ~5)◆
Low materiality Item 5.02, neutral; no comps but ties to Item 7.01 hint at sales guidance stability amid inflation
- No Quant Trends Across Board◆
0/41 disclose YoY/QoQ metrics, insider trades, cap alloc, or guidance changes; uniform absence highlights disclosure minimalism, relative underperformance vs detailed peers
Watch List(8)
Monitor Reg FD details for guidance tied to officer change, potential Q1 2026 pipeline update
Follow-up on Item 7.01 + 5.02 for consumer metrics/leadership impact, near-term earnings call likely
Highest materiality officer shift + Item 7.01, watch SaaS bookings guidance evolution
Item 5.03 amendments post-change, track fund performance/fees thru Feb 2026
Shareholder vote outcomes on governance, renewables sector AGM follow-up
Results + officer change exhibits, monitor insurance loss ratios in next quarterly
Bylaws/votes + change, biotech governance shifts for clinical trial catalysts
- ARCBEST & Schneider National/Transport Pair👁
Comparative Item 7.01 disclosures, watch freight volumes Q1 2026
Filing Analyses(41)
28-01-2026
Zeo ScientifiX, Inc. filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer's identity, position, reason for change, timing, or compensatory arrangements are disclosed.
28-01-2026
The company filed an 8-K on January 28, 2026 (AccNo: 0001140361-26-002589, Size: 254 KB) under Item 5.02 disclosing an officer change event. No specific details on the affected officer's name, title (e.g., CEO, CFO), nature of change (appointment or resignation), reason, or succession context are provided in the filing excerpt. No quantitative metrics, financial impacts, or governance implications are mentioned.
- ·Event date: January 28, 2026
- ·Filing size: 254 KB
- ·AccNo: 0001140361-26-002589
28-01-2026
RPC Inc filed an 8-K on January 28, 2026 (AccNo: 0001104659-26-007185), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the officer involved, position affected, reason for change, or any financial metrics are disclosed. Filing size: 167 KB; sector NOT_DISCLOSED.
28-01-2026
Marine Products Corp filed an 8-K on January 28, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 8.01 covers other events and Item 9.01 lists financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for changes, timing, or any quantitative impacts are disclosed.
28-01-2026
Ultra Clean Holdings, Inc. filed an 8-K on 2026-01-28 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other material data are provided in the filing summary.
28-01-2026
ALT5 Sigma Corp filed an 8-K on January 28, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, names, reasons for change, or any quantitative metrics provided.
28-01-2026
Pacira BioSciences, Inc. filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including officer names, positions affected, appointment or resignation status, reasons, and any financial metrics are NOT_DISCLOSED.
28-01-2026
AiXin Life International, Inc. filed an 8-K on 2026-01-28 (AccNo: 0001493152-26-003883, Size: 226 KB) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons for change, or quantitative data are disclosed.
- ·Sector: sector not specified
28-01-2026
Burke & Herbert Financial Services Corp. filed an 8-K on January 28, 2026 (AccNo: 0001964333-26-000008), disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for the change, timing, or any quantitative financial metrics are disclosed.
- ·Filing size: 167 KB
28-01-2026
El Pollo Loco Holdings, Inc. filed an 8-K on January 28, 2026, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details such as the key position affected, names of individuals, appointment or resignation status, reasons for the change, or timing are disclosed in the provided filing summary. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.
- ·AccNo: 0001104659-26-007246
- ·Filing size: 206 KB
- ·Event date: January 28, 2026
- ·Sector: sector not specified
28-01-2026
US Bancorp (DE) filed an 8-K on January 28, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, or impacts were disclosed.
28-01-2026
FIRST COMMONWEALTH FINANCIAL CORP /PA/ filed an 8-K on 2026-01-28 disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific details on officer identities, positions affected, reasons for change, financial metrics, or performance comparisons are disclosed. No quantitative data, scheduled events, or forward-looking statements are mentioned.
28-01-2026
Perma-Fix Environmental Services Inc. filed an 8-K on January 28, 2026 (AccNo: 0001493152-26-003909), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on individuals affected, nature of changes, reasons, or effective dates are disclosed in the filing summary.
28-01-2026
LOUISIANA-PACIFIC CORP filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details such as the affected position (e.g., CEO, CFO), appointment or resignation status, reasons for change, or any quantitative financial metrics are provided. Filing size is 653 KB with no performance data, positive or negative metrics, or period-over-period comparisons mentioned.
28-01-2026
The company filed an 8-K on January 28, 2026 (AccNo: 0001193125-26-026858) under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as officer names, titles, reasons for the change, appointment vs. resignation status, effective dates, or board composition impacts are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
28-01-2026
Highland Opportunities & Income Fund filed an 8-K on January 28, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 5.03 covers amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 includes financial statements and exhibits; no specific names, reasons, financial impacts, or quantitative details are provided.
28-01-2026
Highland Global Allocation Fund filed an 8-K on January 28, 2026, disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also reports under Item 5.03 amendments to articles of incorporation or bylaws, or a change in fiscal year, and under Item 9.01 includes financial statements and exhibits. No specific names, reasons for changes, quantitative impacts, or other details are disclosed.
28-01-2026
Progressive Corp/OH/ filed an 8-K on January 28, 2026 (AccNo: 0000080661-26-000071, Size: 624 KB), disclosing results of operations and financial condition under Item 2.02, an officer change, departure, election, appointment, or compensatory arrangements under Item 5.02, and financial statements/exhibits under Item 9.01. Specific details on the officer position, name, reason for change, financial metrics, or performance comparisons are NOT_DISCLOSED. No quantitative data, scheduled events, or governance implications are provided in the filing summary.
28-01-2026
Jabil Inc filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Specific details including the affected position, whether it is an appointment or resignation, reasons for the change, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
28-01-2026
Schneider National, Inc. filed an 8-K on January 28, 2026, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the affected officer, position, reason for change, or any quantitative metrics are disclosed. No positive or negative performance metrics are mentioned.
28-01-2026
Workiva Inc filed an 8-K on 2026-01-28 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, individuals involved, reasons for the change, or any financial metrics are disclosed in the provided information. No positive or negative performance metrics are mentioned.
28-01-2026
Ocean Power Technologies, Inc. filed an 8-K on 2026-01-28 disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing also includes Item 5.07 on submission of matters to a vote of security holders and Item 9.01 for financial statements and exhibits. No specific details on affected positions, names, reasons for changes, vote outcomes, or any quantitative metrics are disclosed.
28-01-2026
Valley National Bancorp filed a Form 8-K on 2026-01-28 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for changes, timing, or any quantitative metrics are provided. This is a standard governance disclosure without additional context on implications.
28-01-2026
ARCBEST CORP /DE/ filed an 8-K on January 28, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, individuals involved, reasons for the change, timing, or any financial metrics are disclosed. No quantitative data, performance comparisons, or scheduled events are mentioned.
28-01-2026
The company filed an 8-K on 2026-01-28 (AccNo: 0001091667-26-000011) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the officer involved, position affected, reason for change, effective date, or any quantitative impacts are provided.
28-01-2026
SenesTech, Inc. filed an 8-K on January 28, 2026 (AccNo: 0001628280-26-003828), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions (e.g., CEO, CFO), individuals involved, reasons for the change (e.g., retirement, performance), timing, or any quantitative financial terms are provided in the filing summary. No positive or negative metrics, performance comparisons, or governance impacts are mentioned.
- ·Filing size: 142 KB
- ·Sector: not specified
28-01-2026
Sonoma Pharmaceuticals, Inc. filed an 8-K on January 28, 2026 (AccNo: 0001683168-26-000589, Size: 287 KB), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed.
28-01-2026
TON Strategy Co filed an 8-K on January 28, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
28-01-2026
KB Home filed an 8-K on January 28, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 covers financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.
28-01-2026
Pasithea Therapeutics Corp. filed an 8-K on January 28, 2026, disclosing under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements; under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year; and under Item 5.07 submission of matters to a vote of security holders. No specific details on affected positions, individuals involved, reasons for changes, voting outcomes, amendment contents, or any quantitative metrics are disclosed.
28-01-2026
V F CORP filed an 8-K on 2026-01-28 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or any quantitative data are disclosed. No positive or negative metrics are mentioned.
28-01-2026
Accenture plc filed an 8-K on 2026-01-28 disclosing under Item 5.02 matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 5.07 covers submission of matters to a vote of security holders, while Item 9.01 references financial statements and exhibits. No specific details on personnel changes, voting results, or quantitative metrics are provided in the filing summary.
28-01-2026
Kohl's Corp filed an 8-K on 2026-01-28 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions, names, reasons for change, effective dates, or any quantitative metrics are disclosed.
28-01-2026
Limoneira CO filed an 8-K on January 28, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, reasons, timing, or any quantitative metrics are disclosed.
28-01-2026
COLONY BANKCORP INC filed an 8-K on 2026-01-28 (AccNo: 0000711669-26-000004) reporting results of operations and financial condition under Item 2.02, an officer change or election/appointment under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. Specific details on the leadership change—including position affected, name, appointment/resignation status, reason, or timing—are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other numerical data are disclosed in the provided filing information.
28-01-2026
Lifeward Ltd. filed an 8-K on 2026-01-28 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and submission of matters to a vote of security holders under Item 5.07. Specific details including key position affected, appointment or resignation status, reasons for change, names, and timing are NOT_DISCLOSED. No quantitative data, financial metrics, period-over-period comparisons, or scheduled events are mentioned.
28-01-2026
Zoned Properties, Inc. filed an 8-K on January 28, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and under Item 8.01 for other events. No specific details such as affected positions, names, reasons for change, or timing are disclosed. No quantitative metrics, financial impacts, or performance comparisons are mentioned.
28-01-2026
FTAI Aviation Ltd. filed an 8-K on 2026-01-28 (AccNo: 0001140361-26-002691, Size: 215 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names, reasons for changes, timing, or any quantitative metrics are provided in the filing summary. No positive or negative performance metrics are mentioned.
28-01-2026
Assurant, Inc. filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals, positions, reasons, or financial impacts are disclosed.
28-01-2026
DIAMOND HILL INVESTMENT GROUP INC filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics are provided.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 41 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings